# US 2021/0172936 A1 · Methods for Culturing and for Detecting Stealth Adapted Viruses

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0172936 A1
- Document ID: US20210172936A1
- Status: Published application
- Kind: A1
- Application number: 16/707,961
- Filed: 2019-12-09
- Published: 2021-06-10
- Earliest claimed: 2019-12-09
- Inventors: William John Martin
- Web page: https://patentgrep.com/patent/US20210172936A1

## CPC

- C12Q 1/04: Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor {(C12Q1/6897 takes precedence)}
- G01N 33/5094: {for blood cell populations (red blood cells G01N33/80)}
- C12N 5/0634: {Cells from the blood or the immune system}
- C12N 7/00: Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof (preparing medicinal viral antigen or antibody compositions, e.g. virus vaccines, A61K39/00)
- G01N 21/6428: {Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" (in vivo A61B5/00; immunoassay G01N33/53)}
- G01N 33/56983: {Viruses}
- G01N 33/583: {with non-fluorescent dye label}
- C12N 2500/90: Serum-free medium, which may still contain naturally-sourced components
- C12N 2710/16121: Viruses as such, e.g. new isolates, mutants or their genomic sequences
- C12N 2710/16122: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- G01N 2021/6439: {with indicators, stains, dyes, tags, labels, marks}
- G01N 2800/24: Immunology or allergic disorders
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

Stealth adapted viruses differ from the conventional viruses from which they are derived in not evoking an inflammatory response. This can occur because of the deletion or mutation of the genes coding for the relatively few virus components, which are normally targeted by the cellular immune system. As part of the stealth adaptation process, exchanges can occur between some and possibly all of the sequences of the initiating virus and sequences of both cellular and bacteria origin. A description is provided on the culturing of stealth adapted viruses. A characteristic feature of cultured stealth adapted virus infected cells is the accumulation of intracellular materials, which will fluoresce under ultraviolet (UV) light in the presence of certain dyes including neutral red and acridine orange.

## Claims

### Claim 1

A method of detecting a stealth virus comprising culturing a sample under conditions in which any stealth virus in said sample is able to induce in the cells in which the virus is cultured, the formation of intracellular particulate materials, which will fluoresce under ultraviolet light illumination when the cells are exposed to an appropriate dye, thereby, providing a means of detecting the presence of said stealth virus in the sample.

### Claim 2 (depends on 1)

The method of claim 1, in which the culturing is performed by:
(a) inoculating a permissive cell line with a sample; and (b) detecting the formation of intracellular particulate materials in the permissive cells, which fluoresce under ultraviolet light illumination when exposed to an appropriate dye.

### Claim 3 (depends on 1)

The method of claim 1, in which the culturing is performed by:
(a) inoculating a permissive cell line with a sample; and (b) detecting the formation of extracellular particulate materials in the permissive cells, which fluoresce under ultraviolet light illumination when exposed to an appropriate dye

### Claim 4 (depends on 1)

The method of claim 1, in which the permissive cells being used to detect the presence of a stealth virus are maintained in culture medium, from which the level of KELEA (Kinetic Energy Limiting Electrostatic Attraction) activity has been reduced by exposing the culture medium to sterile paper for a sufficient time prior to the medium being used to culture stealth viruses to have reduced the level of KELEA activity as assessed by the kinetic movement of lidocaine particles sprinkled onto the surface of the medium.

### Claim 5 (depends on 1)

The method of claim 1, in which the permissive cells being used to detect the presence of a stealth virus are maintained in culture medium, which is replaced with fresh medium at more frequent intervals than required to maintain a sufficient supply of nutrients, but rather to reduce the levels of accumulating extracellular materials, which contribute KELEA activity to the medium; a suitable frequency of replacing the medium being 24 to 48 hours.

### Claim 6 (depends on 1)

The method of claim 1, in which the intent on the culturing of the stealth virus in the permissive cells is to obtain cells and/or culture medium from a positive culture to for additional biochemical, immunological, and/or molecular-based assays to further characterize the components, including the genetic sequences, of the particular stealth virus being propagated in the permissive cells.

### Claim 7 (depends on 1)

The method of claim 1, in which the permissive cells being used to detect the presence of a stealth virus, are maintained in serum-free culture medium.

### Claim 8 (depends on 1)

The method of claim 1, in which the appropriate dye for use in staining the cultured permissive cells is neutral red dye at a concentration between 0.001 to 0.05%.

### Claim 9 (depends on 1)

The method of claim 1, in which the appropriate dye for use in staining the cultured permissive cells is acridine orange dye at a concentration between 0.001 to 0.05%.

### Claim 10 (depends on 1)

The method of claim 1, in which the appropriate dye for use in staining the cultured permissive cells is a dye other than neutral red dye or acridine orange dye and includes dyes, which are also easily visible under regular microscopy.

### Claim 11 (depends on 1)

The method of claim 1 in which the sample is blood or cerebrospinal fluid collected from a patient with an illness that is causing neurological and/or psychiatric symptoms.

### Claim 12 (depends on 1)

The method of claim 1 in which the sample is blood-derived mononuclear cells or is cerebrospinal fluid collected from a patient with the chronic fatigue syndrome.

### Claim 13 (depends on 1)

The method of claim 1 in which the sample is blood-derived mononuclear cells or is cerebrospinal fluid collected from a child with autism or with other forms of behavioral and/or emotional disorders.

### Claim 14 (depends on 1)

The method of claim 1 in which the sample is blood-derived materials, other than mononuclear cells, and include serum, plasma, polymorphonuclear cells, erythrocytes, and platelets

### Claim 15 (depends on 1)

The method of claim 1 in which the sample is obtained from blood or blood products intended for transfusions into another individual.

### Claim 16 (depends on 1)

The method of claim 1 in which the sample is obtained from tissue, including a tumor biopsy.

### Claim 17 (depends on 1)

The method of claim 1 in which the sample is obtained from tissue, from an animal.

### Claim 18 (depends on 1)

The method of claim 1 in which the permissive cells are of the same species as the source of the sample in which the presence of a stealth virus is being tested.

### Claim 19 (depends on 1)

The method of claim 1 in which the permissive cells are of a different species from the source of the sample in which the presence of a stealth virus is being tested.

### Claim 20 (depends on 1)

The method of claim 1 in which the sample is blood or cerebrospinal fluid collected from a patient with an autoimmune illness.
